Medical Xpress·3 min read·hard
Emerging mRNA vaccine strategies target cancer and pathogenic viruses in potent new ways
D
Delthia Ricks
✦AI Summary
Researchers at the University of Pennsylvania are developing a new method to reprogram cytotoxic T cells in vivo using mRNA technology. This approach aims to boost the body's natural ability to fight cancer and infectious diseases without the need for external cell processing.
Why it matters
This innovation could significantly simplify and improve the efficacy of immunotherapy, potentially making treatments more accessible and potent.
edited by Stephanie Baum , reviewed by Robert Egan
sciencehealth
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
The article reports on scientific research findings published in a peer-reviewed journal.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in